| Literature DB >> 33126733 |
Simona Daniela Radu Lupoae1, Liliana Mihalcea1, Iuliana Aprodu1, Sonia A Socaci2, Mihaela Cotârleț1, Elena Enachi1, Oana Crăciunescu3, Vasilica Barbu1, Anca Oancea3, Francisc Vasile Dulf4, Petru Alexe1, Gabriela Elena Bahrim1, Gabriela Râpeanu1, Nicoleta Stănciuc1.
Abstract
Lavender flowers were used in this study as a source of phytochemicals as naturally occurring antioxidants. Two different extraction techniques were applied, such as ultrasound-assisted (UAE) and supercritical fluids (SCE) methods. The comparative evaluation of the phytochemicals profile evidenced a higher content of chlorophyll a and b of 5.22 ± 0.12 mg/g dry weight (D.W.) and 2.95 ± 0.16 mg/g D.W, whereas the carotenoids content was 18.24 ± 0.04 mg/g D.W. in the SCE extract. Seven main compounds were found in both extracts: β-linalool, eucalyptol, linalool acetate, β-trans-ocimene, and limonene in SCE and linalool acetate, β-linalool, 6-methyl-2-(2-oxiranyl)-5-hepten-2-ol, linalool oxide, lavandulyl acetate and camphor in UAE. The (n-3) acids had a higher contribution in SCE. The extracts were microencapsulated in different combinations of wall materials based on polysaccharides and milk proteins. The four variants showed different phytochemical and morphological profiles, with a better encapsulating efficiency for proteins (up to 98%), but with a higher content of encapsulated carotenoids for polysaccharides, the latter showing remarkable antimicrobial activity against selected microorganisms. Carboxymethyl cellulose and whey proteins led to a double encapsulation of lipophilic compounds. The powders were tested in two food matrices as ingredients, with multiple targeted functions, such as flavoring, antimicrobial, antioxidant activity that can successfully replace synthetic additives.Entities:
Keywords: added-value; extraction; food flavoring; lavender; microencapsulation; phytochemicals; supercritical fluids extraction
Mesh:
Substances:
Year: 2020 PMID: 33126733 PMCID: PMC7662620 DOI: 10.3390/molecules25215001
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Volatile compounds in lavender of lavender extracts.
| Compound Name | % of Total Peak Areas | ||
|---|---|---|---|
| SCE (S40) | SCE (S45) | UAE | |
| 2-Pentanone, 4-hydroxy-4-methyl- | - | - | 9.24 ± 0.89 * |
| 2(5 | - | - | 0.37 ± 0.10 |
| 1-Hexanol | 0.05 ± 0.01 | 0.08 ± 0.01 | - |
| Tricyclo[2.2.1.0(2,6)]heptane, 1,7,7-trimethyl- | 0.03 ± 0.01 | 0.13 ± 0.02 | - |
| Origanene | 0.06 ± 0.01 | 0.15 ± 0.02 | - |
| α-Pinene | 0.30 ± 0.02 | 0.77 ± 0.04 | - |
| 3-Heptanone, 6-methyl- | 0.11 ± 0.05 | 0.11 ± 0.01 | - |
| Heptane, 2.5.5-trimethyl- | 0.24 ± 0.17 | ||
| Camphene | 0.77 ± 0.09 | 1.97 ± 0.11 | - |
| u.i. | 0.17 ± 0.02 | 0.86 ± 0.11 | - |
| 2-Thujene | 0.04 ± 0.01 | 0.08 ± 0.01 | - |
| 4(10)-Thujene (Sabinen) | 0.10 ± 0.01 | 0.47 ± 0.02 | - |
| β-Pinene | 0.25 ± 0.05 | 0.41 ± 0.03 | - |
| 1-Octen-3-ol | 0.20 ± 0.05 | 0.17 ± 0.01 | - |
| 3-Octanone | 1.30 ± 0.07 | 1.09 ± 0.05 | 0.30 ± 0.10 |
| β-Myrcene | 1.34 ± 0.10 | 1.32 ± 0.11 | 2.83 ± 0.45 |
| Butanoic acid, butyl ester | 0.15 ± 0.01 | 0.18 ± 0.01 | - |
| u.i. | 0.09 ± 0.01 | 0.10 ± 0.01 | - |
| Acetic acid, hexyl ester (1-Hexyl acetate) | 0.85 ± 0.08 | 0.80 ± 0.11 | - |
| α.-Terpinene | 0.08 ± 0.01 | 0.11 ± 0.01 | - |
| 0.83 ± 0.10 | 1.16 ± 0.41 | 0.23 ± 0.01 | |
| Limonene | 3.48 ± 0.54 | 4.87 ± 0.58 | 0.97 ± 0.15 |
| Eucalyptol | 16.72 ± 0.98 | 17.62 ± 1.20 | 2.10 ± 0.08 |
| β- | 4.02 ± 0.45 | 5.13 ± 0.74 | 1.56 ± 0.02 |
| β- | 1.58 ± 0.23 | 1.60 ± 0.12 | 1.48 ± 0.09 |
| γ-Terpinene | 0.16 ± 0.08 | 0.36 ± 0.11 | - |
| 6-Methyl-2-(2-oxiranyl)-5-hepten-2-ol | 3.98 ± 0.23 | 3.45 ± 0.41 | 6.74 ± 1.02 |
| Linalool oxide (fr.1) | 3.04 ± 0.25 | 2.66 ± 0.52 | 5.76 ± 0.28 |
| β-Linalool | 19.94 ± 1.01 | 20.44 ± 1.20 | 15.18 ± 1.20 |
| Octen-1-ol, acetate | 1.01 ± 0.05 | 0.97 ± 0.11 | 1.85 ± 0.07 |
| 2,4,6-Octatriene, 2,6-dimethyl-, (E, Z)- | 0.71 ± 0.11 | 0.58 ± 0.15 | 0.18 ± 0.02 |
| Camphor | 10.3 ± 0.74 | 7.82 ± 1.21 | 4.39 ± 0.23 |
| Lavandulol | 0.35 ± 0.11 | 0.33 ± 0.08 | - |
| Borneol | 1.76 ± 0.25 | 2.38 ± 0.54 | 3.16 ± 0.78 |
| 1-Terpinen-4-ol | 1.41 ± 0.47 | 1.42 ± 0.69 | 1.46 ± 0.03 |
| u.i. | 1.30 ± 0.04 | ||
| Butanoic acid, hexyl ester | - | 0.37 | - |
| 0.44 ± 0.11 | - | - | |
| α-Terpineol | - | 0.20 ± 0.01 | - |
| Isobornyl formate | - | 0.11 ± 0.01 | 0.22 ± 0.01 |
| Linalool acetate | 18.08 ± 0.87 | 15.28 ± 1.25 | 25.86 ± 1.24 |
| Lavandulyl acetate | 2.63 ± 0.56 | 2.13 ± 0.52 | 5.62 ± 0.78 |
| u.i. | 0.15 ± 0.08 | 0.08 ± 0.01 | 1.06 ± 0.06 |
| 8-Hydroxylinalool | - | - | 2.54 ± 0.24 |
| Nerol | 0.14 ± 0.09 | 0.11 ± 0.01 | 0.53 ± 0.08 |
| u.i. ** | 0.38 ± 0.11 | 0.24 ± 0.05 | 1.17 ± 0.09 |
| Caryophyllene | 1.73 ± 0.12 | 1.20 ± 0.02 | 1.86 ± 0.08 |
| α-Bergamotene | 0.08 ± 0.01 | 0.05 ± 0.01 | - |
| β-Farnesene | 0.62 ± 0.22 | 0.49 ± 0.01 | 0.43 ± 0.09 |
| γ-Muurolene | 0.09 ± 0.01 | - | - |
| u.i. | 0.15 ± 0.04 | 0.17 ± 0.01 | 0.98 ± 0.14 |
| Acetic acid. hexyl ester | - | - | 0.39 ± 0.17 |
*—standard deviation, ** unidentified., SCE–supercritical fluid extracts obtained in separator S40 and 45, respectively, UAE–ultrasound-assisted extract.
Fatty acid composition (% of total fatty acids) of lavender extracts.
| Fatty Acids | SCE (S40) | SCE (S45) | UAE |
|---|---|---|---|
| α-linolenic acid (18:3n-3) | 31.67 ± 1.58 * | 25.61 ± 1.25 | 11.82 ± 0.55 |
| Palmitic acid (16:0) | 49.80 ± 2.31 | 25.10 ± 0.87 | 18.71 ± 0.80 |
| Linoleic acid (18:2n-6) | 7.66 ± 1.02 | 16.81 ± 1.05 | 19.66 ± 0.85 |
| Oleic acid (18:1n-9) | 5.37 ± 0.89 | 11.35 ± 0.99 | 27.21 ± 1.10 |
| Stearic acid (18:0) | 1.55 ± 0.25 | 8.39 ± 0.11 | 13.73 ± 0.62 |
| Behenic acid (22:0) | 2.52 ± 0.12 | 5.79 ± 0.35 | 3.58 ± 0.20 |
| Arachidic acid (20:0) | 0.86 ± 0.16 | 5.63 ± 0.52 | 4.62 ± 0.25 |
| Vaccenic acid (18:1n-7) | 0.59 ± 0.11 | 1.31 ± 0.07 | 0.67 ± 0.08 |
| SFAs | 54.73 ± 1.25 | 44.91 ± 1.53 | 40.64 ± 1.35 |
| MUFAs | 5.93 ± 1.20 | 12.66 ± 1.28 | 27.88 ± 1.20 |
| PUFAs | 39.33 ± 1.48 | 42.43 ± 1.87 | 31.48 ± 1.35 |
| 31.67 ± 1.59 | 25.61 ± 0.85 | 11.82 ± 0.55 | |
| 7.66 ± 1.58 | 16.81 ± 0.98 | 19.66 ± 0.90 | |
| 0.24 | 0.66 | 1.66 | |
| PUFAs/SFAs | 0.72 | 0.94 | 0.77 |
Abbreviations: SFAs—saturated fatty acids, MUFAs—monounsaturated fatty acids, PUFAs—polyunsaturated fatty acids. *—standard deviation.
Microencapsulation efficiencies for selected phytochemical (%).
| Selected Parameter | Variant 1 (CMC) | Variant 2 (AG) | Variant 3 (WPI-WPH) | Variant 4 (WPI-CN) |
|---|---|---|---|---|
| Total chlorophylls | 41.97 ± 1.70 c,* | 49.02 ± 1.33 b | 95.22 ± 1.85 a | 94.65 ± 1.44 a |
| Chlorophyll | 38.87 ± 1.43 c | 44.79 ± 0.57 b | 96.62 ± 2.87 a | 98.01 ± 1.56 a |
| Chlorophyll | 43.90 ± 3.56 c | 51.79 ± 2.55 b | 90.61 ± 1.20 a | 90.61 ± 1.36 a |
| Total carotenoids | 49.32 ± 3.16 b | 50.14 ± 2.97 b | 94.79 ± 1.29 a | 97.04 ± 1.20 a |
| Total polyphenols | 61.79 ± 1.98 b | 61.92 ± 1.54 b | 93.88 ± 2.01 a | 93.93 ± 2.01 a |
| Total flavonoids | 73.36 ± 2.87 c | 69.82 ± 1.47 d | 90.22 ± 1.20 b | 90.72 ± 2.47 a |
Values are represented as mean ± standard errors (*). Superscript values that for the same column do not share the same letter (a, b, c and d) are significantly different at p < 0.05 based on the Tukey method. Different encapsulants were used, such as: Variant 1–agar and carboxymethyl cellulose, Variant 2–agar and acacia gum, Variant 3–agar and whey protein isolates and whey protein hydrolysates, Variant 4–agar and whey protein isolates and whey protein casein.
Phytochemical profile of the powders.
| Selected Parameter | Variant 1 (CMC) | Variant 2 (AG) | Variant 3 (WPI-WPH) | Variant 4 (WPI-CN) |
|---|---|---|---|---|
| Total chlorophylls (mg/g D.W.) | 1.54 ± 0.05 a,* | 0.88 ± 0.03 b | 0.43 ± 0.05 c | 0.27 ± 1.44 d |
| Chlorophyll | 0.61 ± 0.01 b | 0.68 ± 0.02 a | 0.17 ± 0.07 c | 0.10 ± 1.56 d |
| Chlorophyll | 0.93 ± 0.10 b | 1.05 ± 0.10 a | 0.27 ± 0.02 c | 0.16 ± 1.36 d |
| Total carotenoids (mg/g D.W.) | 338.70 ± 24.60 a | 339.30 ± 2.39 a | 95.00 ± 1.29 b | 53.82 ± 1.20 c |
| Total polyphenols (mg GAE/g D.W.) | 5.17 ± 0.42 d | 5.47 ± 1.54 c | 9.71 ± 2.01 b | 10.78 ± 0.10 a |
| Total flavonoids (mg CE/g D.W.) | 4.25 ± 0.87 c | 3.98 ± 0.47 d | 6.61 ± 1.20 b | 6.92 ± 0.92 a |
| Antioxidant activity (mMol Trolox/g D.W.) | 2.85 ± 0.12 c | 3.44 ± 0.32 b | 4.77 ± 0.26 a | 4.80 ± 0.15 a |
Values are represented as mean ± standard errors (*). Superscript values that for the same column do not share the same letter (a, b, c and d) are significantly different at p < 0.05 based on the Tukey method.
Figure 1Confocal laser scanning microscopy images of the native variant 1 (a), variant 2 (b), variant 3 (c), variant 4 (d) microencapsulated powders, and of the stained variant 1 (e), variant 2 (f), variant 3 (g), variant 4 (h) microencapsulated powders.
Particle characterization of the microencapsulated powders.
| Variant 1 (CMC) | Variant 2 (AG) | Variant 3 (WPH) | Variant 4 (WPI-CN) | |
|---|---|---|---|---|
| D [2,3], µm | 4.494 | 4.701 | 4.620 | 4.738 |
| D [3,4], µm | 4.684 | 5.048 | 4.909 | 5.108 |
| D10, µm | 3.613 | 3.648 | 3.635 | 3.654 |
| D50, µm | 4.497 | 4.608 | 4.563 | 4.629 |
| D90, µm | 5.698 | 7.612 | 6.665 | 7.860 |
D [2,3]–surface area mean; D [3,4]–volume moment mean; D10, D50 and D90–maximum diameter bellow which 10%, 50% and 90%, respectively, of the samples volume exist.
Figure 2Cell viability on L929 fibroblasts cultured in the presence of microencapsulated powders of lavender extracts. (Variant 1 blue, variant 2 red, variant 3 green and variant 4 purple) after 24 h (a) and 48 h (b). The results were expressed as a relative percentage to the untreated control sample, considered 100% viable. The values represent mean values ± SD (n = 3), * p < 0.05 compared to the control sample.